Digene Founder Headed for the Windy City
Here's a name from the past: Floyd Taub.
He founded Digene, a Gaithersburg biotech company that was recently bought by Qiagen for about $1.6 billion. Taub hadn't been involved in Digene for some time, but just now I got word out of Chicago -- my hometown -- that Taub has turned up as chief executive of a company there called CytoCore.
CytoCore, a privately held startup, is working on developing products for cancer screening and diagnosis. For more information about the company, click here.
---Michael Rosenwald
By
Mike Shepard
|
July 12, 2007; 12:58 PM ET
Previous: Poultry Producer Adding 750 Jobs |
Next: Sunrise Senior Living's Outlines Acting CFO's Pay
Posted by: Roger | July 12, 2007 11:49 PM
CytoCore is a public company trading on the OTC.BB with a ticker symbol of CYCR.OB
Posted by: Roger | July 12, 2007 11:59 PM
CytoCore is a diamond in the rough - to manage to attract Dr. Taub tells the story!
Might be worth investing as long as it's below a buck!
Posted by: Doffen | July 13, 2007 12:25 PM
Cytocore has a long way to go - However, Dr. Taub has a good reputation to bring the products to the market - and when this will happen - CYCR is a great investment opportunity
Posted by: Arno | July 24, 2007 1:38 PM
The comments to this entry are closed.
Yes Dr Taub has another little Hidden Gem on his hands.